Vanguard Personalized Indexing Management
NUVB icon

Vanguard Personalized Indexing Management’s Nuvation Bio NUVB Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
38,876
+4,053
+12% +$19.8K ﹤0.01% 1858
2026
Q1 		$149K Sell
34,823
-1,260
-3% -$7.02K ﹤0.01% 1884
2025
Q4 		$323K Buy
36,083
+1,020
+3% +$6.32K ﹤0.01% 1477
2025
Q3 		$130K Sell
35,063
-1,423
-4% -$3.88K ﹤0.01% 1779
2025
Q2 		$71.1K Buy
36,486
+6,307
+21% +$13.1K ﹤0.01% 1781
2025
Q1 		$53.1K Buy
30,179
+11,168
+59% +$25.4K ﹤0.01% 1669
2024
Q4 		$50.6K Buy
19,011
+2,928
+18% +$7.54K ﹤0.01% 1694
2024
Q3 		$36.8K Buy
16,083
+13
+0.1% +$40 ﹤0.01% 1703
2024
Q2 		$46.9K Sell
16,070
-129
-0.8% -$394 ﹤0.01% 1591
2024
Q1 		$59K Buy
16,199
+147
+0.9% +$282 ﹤0.01% 1557
2023
Q4 		$24.2K Buy
+16,052
New +$20.7K ﹤0.01% 1540

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Personalized Indexing Management's NUVB Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Nuvation Bio (NUVB) stake by 12% in Q2 2026, buying an estimated $19.8K and bringing the position to 38,876 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1858.

Vanguard Personalized Indexing Management first reported a position in NUVB in Q4 2023 and has held it in 11 quarters since. The position peaked at $323K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Vanguard Personalized Indexing Management held 38,876 shares of Nuvation Bio worth $221K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 4,053 Nuvation Bio shares in Q2 2026, an estimated $19.8K.
  • Nuvation Bio made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1858 holding.
  • Vanguard Personalized Indexing Management first reported a position in Nuvation Bio in Q4 2023 and has held it in 11 quarters since.
  • Vanguard Personalized Indexing Management's Nuvation Bio position peaked at $323K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.